MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
7.76
-0.37 (-4.55%)
At close: Mar 25, 2025, 4:00 PM
7.75
-0.01 (-0.13%)
After-hours: Mar 25, 2025, 5:50 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $259.37 million as of March 25, 2025.
Market Cap
259.37M
Enterprise Value
-1.60M
1-Year Change
n/a
Ranking
Category
Stock Price
7.76
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $259.37M, a decrease of -49.11%. That is a compound annual growth rate of -72.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2025 | 260.38M | -57.72% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 752.28B |
| UnitedHealth Group | 472.77B |
| Johnson & Johnson | 394.32B |
| AbbVie | 370.74B |
| Novo Nordisk | 340.37B |
| Merck & Co. | 235.20B |
| AstraZeneca | 232.35B |
| Novartis AG | 221.84B |